DUSP22 and metabolic dysfunction-associated steatohepatitis: In the study, we, for the first time, discovered that ROS modulated DUSP22 degradation and substantially facilitated NASH development, while NAC treatment upregulated DUSP22 expression levels, protecting hepatocytes and liver tissues from damage under oxidative or metabolic stresses.